Related references
Note: Only part of the references are listed.Impairment of B-cell functions during HIV-1 infection
Sylvie Amu et al.
AIDS (2013)
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission
Jennifer D. Watkins et al.
AIDS (2013)
Broadly Neutralizing Antiviral Antibodies
Davide Corti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Safety and Immunogenicity of DNA Prime and Modified Vaccinia Ankara Virus-HIV Subtype C Vaccine Boost in Healthy Adults
Peter Hayes et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Antibody-Dependent Enhancement and the Risk of HIV Infection
Andrea Gorlani et al.
CURRENT HIV RESEARCH (2013)
Infectious diseases in humanized mice
Carol Leung et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Vaccine adjuvants: the future is bright
Jenaid Rees et al.
EXPERT REVIEW OF VACCINES (2013)
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
Andrew T. McGuire et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Neutralizing antibodies to HIV-1 induced by immunization
Laura E. McCoy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Immune Focusing and Enhanced Neutralization Induced by HIV-1 gp140 Chemical Cross-Linking
T. Schiffner et al.
JOURNAL OF VIROLOGY (2013)
Immune clearance of highly pathogenic SIV infection
Scott G. Hansen et al.
NATURE (2013)
GLOBAL HEALTH Designing Tomorrow's Vaccines
Gary J. Nabel
NEW ENGLAND JOURNAL OF MEDICINE (2013)
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
Joshua A. Horwitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Phenotypic properties of transmitted founder HIV-1
Nicholas F. Parrish et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
Jean-Philippe Julien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Development of prophylactic vaccines against HIV-1
Torben Schiffner et al.
RETROVIROLOGY (2013)
STRUCTURAL BIOLOGY Is High-Tech View of HIV Too Good to Be True?
Jon Cohen
SCIENCE (2013)
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Jean-Philippe Julien et al.
SCIENCE (2013)
Accelerating Next-Generation Vaccine Development for Global Disease Prevention
Wayne C. Koff et al.
SCIENCE (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition
David Lutje Hulsik et al.
PLOS PATHOGENS (2013)
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
Jean-Philippe Julien et al.
PLOS PATHOGENS (2013)
Llama Antibody Fragments Have Good Potential for Application as HIV Type 1 Topical Microbicides
Andrea Gorlani et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice
Eun Mi Hur et al.
BLOOD (2012)
A Blueprint for HIV Vaccine Discovery
Dennis R. Burton et al.
CELL HOST & MICROBE (2012)
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
Laura E. McCoy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
Jorge Reyes-del Valle et al.
JOURNAL OF VIROLOGY (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody
Daniela Tudor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The changing face of HIV vaccine research
Peter D. Kwong et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2012)
The Antibody Response against HIV-1
Julie Overbaugh et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Overview and outlook of Toll-like receptor ligand-antigen conjugate vaccines
Yoshio Fujita et al.
THERAPEUTIC DELIVERY (2012)
Attenuation of HIV-associated human B cell exhaustion by siRNA down regulation of inhibitory receptors
Lela Kardava et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2011)
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
L. A. Lagenaur et al.
MUCOSAL IMMUNOLOGY (2011)
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
Suzanne Willey et al.
RETROVIROLOGY (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Origins of HIV and the AIDS Pandemic
Paul M. Sharp et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques
Kehmia Titanji et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference
Anna Laura Ross et al.
LANCET INFECTIOUS DISEASES (2010)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Davide Corti et al.
PLOS ONE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Vaccine adjuvants: A priority for vaccine research
Ali M. Harandi et al.
VACCINE (2010)
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
Kuan-Hsiang G. Huang et al.
NATURE COMMUNICATIONS (2010)
HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis
D. Tudor et al.
MUCOSAL IMMUNOLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children
Simone Pensierosoa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
Christopher M. Coleman et al.
RETROVIROLOGY (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Prevention strategies against small ruminant lentiviruses: An update
Ramses Reina et al.
VETERINARY JOURNAL (2009)
Fc receptor-mediated antiviral antibodies
Donald N. Forthal et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development
Silvia Baroncelli et al.
EXPERT REVIEW OF VACCINES (2008)
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals
Susan Moir et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Why is HIV a pathogen?
Anna Forsman et al.
TRENDS IN MICROBIOLOGY (2008)
Humoral immunity to HIV-1: neutralisation and antibody effector functions
Suzanne Willey et al.
TRENDS IN MICROBIOLOGY (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women
T. Hirbod et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection
Kehmia Titanji et al.
BLOOD (2006)
The PD-1-PD-L pathway in immunological tolerance
T Okazaki et al.
TRENDS IN IMMUNOLOGY (2006)
Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type I infection
MMI Aasa-Chapman et al.
JOURNAL OF VIROLOGY (2005)
Live attenuated HIV vaccines: pitfalls and prospects
JB Whitney et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2004)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
K Broliden et al.
IMMUNOLOGY LETTERS (2001)
Share Paper
